Filter
1437
Filtered Results: 1437
Text search:
detección
y
diagnóstico
Featured
Recommendations
143
New Publications
300
Language
Document type
No document type
684
Guidelines
320
Studies & Reports
229
Manuals
82
Strategic & Response Plan
63
Fact sheets
31
Training Material
11
Situation Updates
9
Brochures
3
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
Western and Central Europe
78
Latin America and the Carribbean
71
India
60
Global
51
Paraguay
37
Colombia
36
Peru
29
Africa
29
South Africa
26
Argentina
26
Eastern Europe
26
Rwanda
22
West and Central Africa
22
Kenya
21
East and Southern Africa
20
Nigeria
18
Bolivia
18
Middle East and North Africa
18
Sierra Leone
17
Liberia
17
Ethiopia
17
El Salvador
17
Ecuador
16
Uganda
15
Brazil
13
Eastern Europe and Central Asia
13
Venezuela
13
Tanzania
12
Bangladesh
12
Malawi
12
Russia
11
Senegal
10
Philippines
10
Ukraine
10
Chile
10
Ghana
9
Cambodia
9
Zambia
8
Mozambique
8
Myanmar / Burma
8
Burkina Faso
7
Nepal
7
Germany
7
Syria
7
South–East Asia Region
7
Zimbabwe
6
Asia
5
Guinea
4
Congo, Democratic Republic of
4
Cameroon
4
Pakistan
4
North America
4
Spain
4
Mali
3
USA
3
Indonesia
3
Sudan
3
Dominican Republic
3
Namibia
3
Honduras
3
Angola
3
Madagascar
3
Uruguay
3
Saudi Arabia
2
Thailand
2
Benin
2
Timor Leste/ East Timor
2
Georgia
2
France
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Singapore
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Burundi
1
Botswana
1
Greece
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Other region
1
Albania
1
Mongolia
1
Laos
1
Congo-Brazzaville
1
Iran
1
Vietnam
1
Turkmenistan
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
588
Clinical Guidelines
223
Public Health
105
Pharmacy & Technologies
47
Women & Child Health
41
Key Resources
27
Capacity Building
10
Toolboxes
TB
267
COVID-19
164
Mental Health
87
Rapid Response
86
NTDs
85
HIV
70
AMR
44
NCDs
36
Ebola
30
Zika
25
Caregiver
22
Pharmacy
22
Planetary Health
18
Disability
14
Cholera
12
Polio
11
Refugee
11
Global Health Education
9
Conflict
7
Specific Hazards
3
Health Financing Toolbox
3
Natural Hazards
1
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification test...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen ... tests (RADT) to their testing strategies in order to reduce pressure on RT-PCR testing.
Some Member States have already included RADT in their case definition.
The main bottlenecks, such as shortages of laboratory consumables and human resources, as well as sample storing facilities, continue to exist and may affect the overall laboratory response to COVID-19.
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform m...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decon...
This document has been developed for the WHO Regional Office for the Eastern Mediterranean to establish a regional plan of action to support the countries of the Region to rapidly accelerate the scaling up of their capacities for the prevention and early ... of, and rapid response to, coronavirus disease 2019 (COVID-19), as required under the International Health Regulations (IHR 2005). The regional plan is aligned with the WHO global 2019 novel coronavirus strategic preparedness and response plan, but tailored to the regional context.
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid ... tests for population screening, a single-dose oral treatment and a highly efficient vector control strategy, interruption of transmission of the causative parasite is now within reach. If indeed gHAT has an exclusively human reservoir, this could even result in eradication of the disease. Even if there were an animal reservoir, on the basis of epidemiological data, it plays a limited role. Maintaining adequate postelimination surveillance in known historic foci, using the newly developed tools, should be sufficient to prevent any future resurgence.
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The purpose of cancer screening tests is to detect pre-cancer or early-stage cancer in asymptomatic individuals so that timely diagnosis and early treatment can be offered, where this treatment can lead to better outcomes for some people.
The aim of a cancer screening programme is either to reduc...
It summarizes guidance on how to manage – and when to refer – children and adolescents presenting with common complaints and conditions. It includes information to enable primary health care providers to coordinate the continued care of children and adolescents with long-term conditions and dise...
Journal of Tropical Pediatrics, 2020, 00, 1–5
doi: 10.1093/tropej/fmaa072
Brief Repor
Mission report: June 11-20, 2017
WHO Guidelines for malaria
recommended
25 Nov 2022
The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO Guidelines for malaria supersedes 2 previous WHO publications: the Guidelines for the treatment of mala...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr...
Guidance on pooled testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
recommended
The purpose of this document is to provide guidance on the use of pooled sample testing strategy in coronavirus disease (COVID-19)
testing laboratories of the African Union Member States for scaling up SARS-CoV-2 nucleic acid testing capacity with the available resources. The current document descr...
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing...
